HELSINKI, March 23 (Xinhua) -- The National Public Health Institute of
Finland on Thursday signed a contract to buy bird fluvaccines from the Dutch
drug maker Solvay Pharmaceuticals.
Under the contract worth 20.8 million euros (about 25.0 millionU.S. dollars), Finland will be
able to get enough H5N1 vaccine doses for its entire population.
It is also hoped that the vaccine would provide some degree of protection
against a feared mutation of the bird flu virus into a form that could be
transmitted from person to person. Enditem